Kyri K. Van Hoose SEC EDGAR Filings (CIK 0001860885)

SEC EDGAR filings, ownership reports, and insider transactions for Kyri K. Van Hoose.

Business address
C/O Turning Point Therapeutics, Inc., 10628 Science Center Drive, Suite 200, San Diego, CA, 92121
Top holdings (ownership)
DRMA
Get insider transactions for this reporting owner
Kyri K. Van Hoose has filed 10 SEC EDGAR filings since 14 May 2021

Latest Filings

Recent SEC filings for Kyri K. Van Hoose including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 06 Jan 2026 02 Jan 2026 001-40739
4 Open 4 document View SEC filing for 4 29 Dec 2025 23 Dec 2025 001-40739
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 23 Jan 2025 21 Jan 2025 001-40739
4 Open 4 document View SEC filing for 4 FORM 4 14 Jan 2025 13 Jan 2025 001-40739
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 05 Jan 2024 04 Jan 2024 001-40739
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 05 Jan 2023 03 Jan 2023 001-40739
4 Open 4 document View SEC filing for 4 05 Jan 2022 03 Jan 2022 001-40739
4 Open 4 document View SEC filing for 4 01 Sep 2021 01 Sep 2021 001-40739
3 Open 3 document View SEC filing for 3 01 Sep 2021 01 Sep 2021 001-40739
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 14 May 2021 14 May 2021 001-38871

About this filer

Kyri K. Van Hoose files with the SEC under CIK 0001860885. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages